CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net income	$ 171,498	$ 561,108
Adjustments to reconcile net income to net cash provided from operating activities:
Deferred income tax expense	9,820	149,289
Depletion, depreciation and amortization	265,872	259,197
Abandonment and impairment of unproved properties	8,618	44,308
Derivative fair value income	(110,530)	(530,095)
Cash settlements on derivative financial instruments	362,695	188,496
Divestiture contract obligation, including accretion	27,933	71,380
Amortization of deferred financing costs and other	3,352	3,591
Deferred and stock-based compensation	37,597	60,166
Gain on the sale of assets	(222)	(353)
Gain on early extinguishment of debt	(254)	(439)
Changes in working capital:
Accounts receivable	101,530	288,415
Other current assets	(1,809)	(9,520)
Accounts payable	(27,052)	(84,291)
Accrued liabilities and other	(122,424)	(249,455)
Net cash provided from operating activities	726,624	751,797
Investing activities:
Additions to natural gas properties	(432,264)	(421,087)
Additions to field service assets	(1,371)	(321)
Acreage purchases	(44,787)	(27,422)
Proceeds from disposal of assets	273	823
Purchases of marketable securities held by the deferred compensation plan	(36,681)	(39,545)
Proceeds from the sales of marketable securities held by the deferred compensation plan	42,225	43,663
Net cash used in investing activities	(472,605)	(443,889)
Financing activities:
Borrowings on credit facility	0	185,000
Repayments on credit facility	0	(204,000)
Repayment of senior notes	(69,846)	(60,934)
Dividends paid	(58,127)	(57,949)
Treasury stock purchases	(44,136)	(9,663)
Taxes paid for shares withheld	(25,201)	(39,475)
Change in cash overdrafts	(9,070)	(18,616)
Proceeds from the sales of common stock held by the deferred compensation plan	17,837	60,323
Net cash used in financing activities	(188,543)	(145,314)
Increase in cash and cash equivalents	65,476	162,594
Cash and cash equivalents at beginning of period	211,974	207
Cash and cash equivalents at end of period	$ 277,450	$ 162,801